Abpro withdraws IPO

Antibody company Abpro Corp. (Woburn, Mass.) is withdrawing a planned IPO on NASDAQ, according to an SEC filing on May 16. Underwriters were to be UBS, Wells Fargo, Nomura and Oppenheimer.

Earlier this month, Abpro said it aimed to sell 4 million shares at $14-$16. At the $15 midpoint, a sale of that many shares would have raised $60 million and valued the company at $281.3 million...